A study of inflammation in patients whohave recovered from Covid-19 pneumonia

  • Funded by National Health and Medical Research Council (NHMRC)
  • Total publications:0 publications

Grant number: GA148995

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2021
    2022
  • Known Financial Commitments (USD)

    $260,667.99
  • Funder

    National Health and Medical Research Council (NHMRC)
  • Principal Investigator

    N/A

  • Research Location

    Australia
  • Lead Research Institution

    UNIVERSITY OF WESTERN AUSTRALIA
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Inflammation has an important role in the development of cardiovascular disease. COVID-19 is associated with a high rate of lung infection. In this project we aim to study if there are persistent areas of inflammation (on 18-FDG-PET/CT inflammation) in the aorta and lungs in patients who have recovered clinically from COVID-19 pneumonia as it may predict increased risk for future heart disease. If this study shows that persisting lung inflammation is associated with increased blood vessel inflammation, affected patients may require additional treatment to reduce cardiovascular consequences. This project combines the expertise of leading Cardiologists and Nuclear Medicine researchers in Australia and India.